SCHEMBL19968129

SCHEMBL19968129

Cc1nc(Nc2ncc(F)c(-c3cc(F)c4nc(C)n(C(C)C)c4c3)n2)ccc1C(=O)N1CCCN(CCN(C)C)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.64
CDK2 P24941 20/20 0.64
CDK6 Q00534 20/20 0.64
CDK1 P06493 9/20 0.64
CDK7 P50613 9/20 0.64
CDK9 P50750 9/20 0.64
CCNA2 P20248 8/20 0.64
CCND3 P30281 8/20 0.64
CCNB1 P14635 4/20 0.64
CCNE1 P24864 4/20 0.64
CDK5 Q00535 4/20 0.64
CHEK1 O14757 1/20 0.64
CCNT1 O60563 1/20 0.64
JAK2 O60674 1/20 0.64
CHEK2 O96017 1/20 0.64
EGFR P00533 1/20 0.64
RAF1 P04049 1/20 0.64
NTRK1 P04629 1/20 0.64
PDGFRB P09619 1/20 0.64
SRC P12931 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19968040 0.91 CDK4 (0.66) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968062 0.90 CDK4 (0.57) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968116 0.90 CDK4 (0.64) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968034 0.90 CDK4 (0.64) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968032 0.89 CDK4 (0.63) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968055 0.89 CDK4 (0.61) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968054 0.85 CDK4 (0.62) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968123 0.85 CDK4 (0.61) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19968045 0.85 CDK4 (0.61) CDK4CDK2CDK6CDK1CDK7
SCHEMBL19967971 0.85 CDK4 (0.62) CDK4CDK2CDK6CDK1CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018045956-A1 BENZIMIDAZOLE COMPOUND KINASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏豪森药业集团有限公司 2018-03-15 WO disclosed